Short Interest in Corindus Vascular Robotics Inc (CVRS) Rises By 5.4%

Corindus Vascular Robotics Inc (NYSEAMERICAN:CVRS) was the target of a large increase in short interest in February. As of February 28th, there was short interest totalling 14,185,466 shares, an increase of 5.4% from the February 15th total of 13,464,882 shares. Based on an average trading volume of 1,024,884 shares, the short-interest ratio is currently 13.8 days. Approximately 24.0% of the shares of the stock are short sold.

Separately, Zacks Investment Research upgraded shares of Corindus Vascular Robotics from a “hold” rating to a “buy” rating and set a $1.00 target price on the stock in a research report on Monday, November 13th. Three equities research analysts have rated the stock with a sell rating and two have assigned a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average target price of $2.33.

How to Become a New Pot Stock Millionaire

Hedge funds have recently made changes to their positions in the stock. Goldman Sachs Group Inc. lifted its holdings in Corindus Vascular Robotics by 147.8% during the 2nd quarter. Goldman Sachs Group Inc. now owns 58,824 shares of the medical equipment provider’s stock valued at $109,000 after purchasing an additional 35,086 shares during the last quarter. New York State Common Retirement Fund lifted its holdings in Corindus Vascular Robotics by 334.6% during the 2nd quarter. New York State Common Retirement Fund now owns 89,100 shares of the medical equipment provider’s stock valued at $166,000 after purchasing an additional 68,599 shares during the last quarter. Deutsche Bank AG lifted its holdings in Corindus Vascular Robotics by 91.6% during the 4th quarter. Deutsche Bank AG now owns 250,179 shares of the medical equipment provider’s stock valued at $251,000 after purchasing an additional 119,611 shares during the last quarter. California State Teachers Retirement System lifted its holdings in Corindus Vascular Robotics by 34.4% during the 2nd quarter. California State Teachers Retirement System now owns 148,558 shares of the medical equipment provider’s stock valued at $276,000 after purchasing an additional 38,000 shares during the last quarter. Finally, Teachers Advisors LLC lifted its holdings in Corindus Vascular Robotics by 184.7% during the 2nd quarter. Teachers Advisors LLC now owns 167,633 shares of the medical equipment provider’s stock valued at $312,000 after purchasing an additional 108,745 shares during the last quarter.

Corindus Vascular Robotics (CVRS) opened at $1.28 on Friday. Corindus Vascular Robotics has a 1-year low of $0.66 and a 1-year high of $2.25. The stock has a market cap of $228.33, a PE ratio of -5.33 and a beta of 18.81.

TRADEMARK VIOLATION WARNING: This report was first posted by Sports Perspectives and is the property of of Sports Perspectives. If you are reading this report on another publication, it was stolen and reposted in violation of United States and international trademark and copyright law. The original version of this report can be viewed at https://sportsperspectives.com/2018/03/10/short-interest-in-corindus-vascular-robotics-inc-cvrs-rises-by-5-4.html.

About Corindus Vascular Robotics

Corindus Vascular Robotics, Inc is engaged in robotic-assisted vascular interventions. The Company’s CorPath System is a medical device that brings robotic-assisted precision to radial, coronary and peripheral procedures. The workstation allows the physician greater control and the freedom from wearing heavy lead protective equipment that causes musculoskeletal injuries.

Receive News & Ratings for Corindus Vascular Robotics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Corindus Vascular Robotics and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply